Marshall Wace North America L.P. - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$107,000
-85.7%
46,371
-55.0%
0.00%
-100.0%
Q1 2021$748,000
+759.8%
103,087
+613.2%
0.00%
+200.0%
Q2 2020$87,000
-17.1%
14,455
+89.1%
0.00%0.0%
Q4 2019$105,000
-94.3%
7,646
-94.1%
0.00%
-90.9%
Q2 2019$1,827,000130,5720.01%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 6,449,856$8,514,0002.83%
RA Capital Management 9,694,789$12,797,0000.23%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$9,173,0000.19%
HARBOR CAPITAL ADVISORS, INC. 275,870$364,0000.13%
Artal Group S.A. 1,803,858$2,381,0000.06%
GSA CAPITAL PARTNERS LLP 338,756$447,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 1,335,174$1,762,0000.05%
PVG ASSET MANAGEMENT CORP 10,000$13,200,0000.05%
Anson Funds Management LP 348,266$460,0000.04%
Eversept Partners, LP 419,581$553,8470.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders